Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol in COPD Patients Undergoing Laparoscopic Surgery
ChiCTR2500109433Phase 4Not yet recruiting
- Sponsor
- Shanghai First People's Hospital Jiuquan Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Shanghai First People's Hospital Jiuquan Hospital. Primary endpoints: Cardiac Output (CO), Right ventricular area change fraction (RV-FAC) and 2 more. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2500109433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109433.